Venus Medtech (Hangzhou) Inc. (2500.HK) HKSE

2.90

+0.11(+3.94%)

Updated at February 20 04:08PM

Currency In HKD

Valuation

Market Cap2.31B
Enterprise Value2.38B
P/E Ratio-1.75
PEG Ratio-0.18
Price/Sales Ratio2.63
Price/Book Ratio0.54
Enterprise/Revenue3.13
Enterprise/EBITDA-2.34

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-1.5
Operating Margin-0.65

Management Effectiveness

Return On Assets-0.21
Return On Equity-0.3

Income Statement

Revenue470.83M
Revenue/Share0.98
Gross Profit367.75M
EBITDA-612.96M
Net Income-714.31M
Diluted EPS-1.63

Balance Sheet

Total Cash293.31M
Total Cash/Share0.67
Total Debt493.59M
Total Debt/Equity0.24
Current Ratio1.82
Book Value Per Share4.72

Price History

52-Week Change-48.4
52-Week High5.62
52-Week Low1.59
Moving Average 50 Days2.73
Moving Average 200 Days2.95

Statistics

Average Volume1.76M
Shares Outstanding437.9M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A